Surgepays Q4 2023 GAAP EPS $0.19 Misses $0.41 Estimate, Sales $32.318M Miss $33.521M Estimate
Portfolio Pulse from Benzinga Newsdesk
Surgepays reported its Q4 2023 earnings with a GAAP EPS of $0.19, missing the consensus estimate of $0.41 by 53.66%. Quarterly sales were $32.318M, also below the estimate of $33.521M by 3.59%, marking a 10.79% decrease from the same period last year.
March 12, 2024 | 8:06 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Surgepays missed Q4 2023 earnings and sales estimates, with a significant EPS miss and a slight sales miss, indicating a year-over-year decline.
The significant miss in both earnings per share and sales compared to analyst estimates, coupled with a year-over-year sales decline, suggests a negative short-term impact on SURG's stock price. The magnitude of the miss, especially in EPS, is likely to shake investor confidence and could lead to a decrease in stock price as the market adjusts to the new information.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100